Palbociclib, developed by Pfizer for certain types of advanced breast cancer, was approved for sale in 2015.

South China Morning Post

Hong Kong

CR Pharma, NAMI join forces to fight Alzheimer’s with Pfizer cancer drug

Ad Fontes Media

All Sides

Media Bias/Fact Check

Alibaba Group

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's...

Globe Newswire

Apollo Global Management

Alzheimer's Drugs Market Report and Forecast 2024-2032, Competitive Analysis of F. Hoffmann-La Roche, Novartis, Merck Sharp & Dohme, Biogen, AbbVie, Eisai, J&J, Daiichi Sankyo, and Ono Pharma

New Delhi: New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed that the growth will particularly be visible in eight major markets — US, France, Germany, Italy, Spain, UK, Japan, and China. The report forecasted that the Alzheimer’s disease market in these countries to grow from $2.4 billion in 2023 …

The Siasat Daily

Costly therapies to foster Alzheimer’s market growth globally: Report

Last Updated on January 14, 2025 by New Delhi, Jan 14 (IANS) New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed that the growth will particularly be visible in eight major markets — US, France, Germany, […] The post Costly therapies to foster Alzheimer’s market growth globally: Report appeared first…

THIP Media

Costly therapies to foster Alzheimer’s market growth globally:...

The global Alzheimer’s disease (AD) market across the eight major markets (8MM*) is forecast to grow from $2.4 billion in 2023 to $19.3 billion by 2033 at a compound annual growth rate (CAGR) of 23.4 per cent, primarily driven by the entry of expensive disease-modifying therapies (DMTs) into the market, which will likely result in increased treatment rates as more options become available, an aging global population leading to an increase in pre…

Express Pharma

Global Alzheimer’s disease market to reach $19.3 bn in 8MM by 2033 - Express Pharma

New Delhi, Jan 14 (SocialNews.XYZ) New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed that the growth will particularly be visible in eight major markets -- US, France, Germany, Italy, Spain, UK, Japan, and China. The report forecasted that the Alzheimer’s disease market in these countries to grow f…

Social News XYZ

During this month, Canadians are encouraged to learn more about dementia and its impact

pipestoneflyer.ca

Wetaskiwin

County Of Wetaskiwin No. 10

Alberta

Canada

AHS: January is Alzheimer's Awareness Month

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) — The “Alzheimer’s Drugs Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering. The Alzheimer’s drugs market was valued at USD 7.7 billion in 2023, driven by the increasing aging population and rising awareness about Alzheimer’s disease and related dementia across the 8 major markets. The market is expected to grow at a CAGR of 5.3% during the forecast period of 20…

dailyguardian.ca

Alzheimer’s Drugs Market Report and Forecast 2024-2032, Competitive Analysis of F. Hoffmann-La Roche, Novartis, Merck Sharp & Dohme, Biogen, AbbVie, Eisai, J&J, Daiichi Sankyo, and Ono Pharma

News Room Odisha

New Delhi, Jan 14 (IANS) New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and… Continue reading Costly therapies to foster Alzheimer’s market growth globally: Report The post Costly therapies to foster Alzheimer’s market growth globally: Report first appeared on Australia India News.

CR Pharma, NAMI join forces to fight Alzheimer’s with Pfizer cancer drug

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics